|SEQ_NO||1||Date of announcement||2022/08/11||Time of announcement||13:34:30|
|Subject||Announcement of TTY Biopharm's unaudited income information in July 2022|
|Date of events||2022/08/11||To which item it meets||paragraph 53|
|Statement||1.Date of occurrence of the event:2022/08/11
2.Company name:TTY Biopharm Co., Ltd.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $384,643 thousands (expressed in NT dollars; unaudited), a consolidated operating profit of $91,936 thousands, and a consolidated income before tax of $101,968 thousands in July 2022; net income attributed to stockholders of the company was $82,908 thousands; EPS is $0.33.
Year-to-date consolidated net sales was $2,587,275 thousands (in NT dollars; unaudited), a consolidated operating profit was $636,215 thousands and consolidated income before tax was $740,242 thousands until July 2022; year-to-date net income attributed to stockholders of the company was $594,578 thousands; EPS is $2.39.
7.Any other matters that need to be specified:
The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail.